[Drug immunosuppression].
D000477:Alkylating Agents / Q000627:therapeutic use; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy; D000963:Antimetabolites / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy; D001171:Arthritis, Juvenile / Q000188:drug therapy; D001215:Asparaginase / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001402:B-Lymphocytes; D002648:Child; D002908:Chronic Disease; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003609:Dactinomycin / Q000627:therapeutic use; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008938:Mitosis; D010396:Penicillamine / Q000627:therapeutic use; D010950:Plasma Cells; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy; D013601:T-Lymphocytes
D000477:Alkylating Agents; D000963:Antimetabolites; D007166:Immunosuppressive Agents; D003609:Dactinomycin; D001215:Asparaginase; D010396:Penicillamine
Medikamentöse Immunsuppression